Additionally, RSK2 kinase significantly enhances LARG's GEF activity by phosphorylating Ser1288, a modification particularly critical for tumor cell bleb‐based invasion upon EGF or serum stimulation [124]. Here, ARHGEF2 is linked to neoplasm.